By: Linda L. Goodman
The Federal Trade Commission (“FTC”) has joined with the Food and Drug Administration (“FDA”) in sending warning letters to companies selling health related products to ensure the products are advertised truthfully, and that efficacy claims for the products are supported by competent and reliable scientific evidence.
The FTC has reviewed the advertisements for Gold Crown Natural Products, TEK Naturals and Pure Nootropics, LLC and believe that the companies may have violated the FTC Act by making false or unsubstantiated health claims. The FTC is specifically concerned about advertisements that claim to treat Alzheimer’s, Parkinson’s, heart disease and cancer.
As an example of the claims made are, as follows:
- “Many experiments have been conducted on this and it is proved that melatonin supplements are used to cure Alzheimer’s disease.”
- “[c]linically shown to help diseases of the brain such as Alzheimer’s and even dementia.”
- Advertisements that claim benefits for dementia, schizophrenia, Alzheimer’s, and Parkinson’s, among others.
The letters are warnings and require the companies to contact the two agencies within 15 days regarding the agency’s concerns.
For more information and to view the full Press Release, go to the FTC’s website here:
______________________________________________________________________
This article is a publication of The Goodman Law Firm and is intended to provide information on recent legal developments. This article does not create an attorney-client relationship, nor should it be construed as legal advice or an opinion on specific situations. This may constitute “Attorney Advertising” under the Rules of Professional Conduct and under the law of other jurisdictions.
Linda L. Goodman is the founder of The Goodman Law Firm, concentrating its practice in internet business and law. Her firm’s clients include Advertisers, Affiliates, Affiliate Networks, and ISP’s.
© 2019 TGLF, A.P.C.